Company / Revenue
ENvue Medical, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.6M
FY2025
5-year range
$623.0K / $2.6M
FY2021-FY2025
Trend
+12.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $752,000 to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +37.0%.
Improved from $752,000 to $3M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +14.7%
- 5-Year CAGR
- +37.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +37.0%, indicating consistent growth.
- In FY2025, revenue increased 12.0% year-over-year.
- Lowest revenue in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.6M | +12.0% |
| FY2024 | $2.3M | +203.6% |
| FY2023 | $752.0K | -55.6% |
| FY2022 | $1.7M | +172.1% |
| FY2021 | $623.0K | +17.5% |
| FY2020 | $530.0K | +66.7% |
| FY2019 | $318.0K | +33.1% |
| FY2018 | $239.0K | +4.4% |
| FY2017 | $229.0K | +55.8% |
| FY2016 | $147.0K | -27.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026